An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19.

Homolak, Jan; Kodvanj, Ivan; Trkulja, Vladimir

Homolak, Jan; Kodvanj, Ivan; Trkulja, Vladimir.

Homolak J; Department of Pharmacology, University of Zagreb School of Medicine, 10 000, Zagreb, Croatia. homolakjan@gmail.com.
Kodvanj I; Department of Pharmacology, University of Zagreb School of Medicine, 10 000, Zagreb, Croatia.
Trkulja V; Department of Pharmacology, University of Zagreb School of Medicine, 10 000, Zagreb, Croatia.

Clin Drug Investig ; 41(3): 287-289, 2021 03.

Article in English | MEDLINE | ID: covidwho-1091998

Subject(s)

COVID-19; Virus Diseases; Humans; Proton Pump Inhibitors/adverse effects; Risk Factors; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Virus Diseases / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Clin Drug Investig Journal subject: Pharmacology / Drug Therapy Year: 2021 Document Type: Article Affiliation country: S40261-021-01007-8

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google